Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1,500 29 34 29 34 B-lower_bound
cells/µL 35 43 35 43 I-lower_bound

Active 0 6 44 50 O
heart 7 12 51 56 B-chronic_disease
disease 13 20 57 64 I-chronic_disease
including 21 30 65 74 O
myocardial 31 41 75 85 B-chronic_disease
infarction 42 52 86 96 I-chronic_disease
within 53 59 97 103 O
previous 60 68 104 112 B-upper_bound
3 69 70 113 114 I-upper_bound
months 71 77 115 121 I-upper_bound
, 77 78 121 122 O
symptomatic 79 90 123 134 B-chronic_disease
coronary 91 99 135 143 I-chronic_disease
artery 100 106 144 150 I-chronic_disease
disease 107 114 151 158 I-chronic_disease
or 115 117 159 161 O
heart 118 123 162 167 B-chronic_disease
block 124 129 168 173 I-chronic_disease
, 129 130 173 174 O
or 131 133 175 177 O
uncontrolled 134 146 178 190 O
congestive 147 157 191 201 B-chronic_disease
heart 158 163 202 207 I-chronic_disease
failure 164 171 208 215 I-chronic_disease

Aspartate 0 9 216 225 B-clinical_variable
aminotransferase 10 26 226 242 I-clinical_variable
( 27 28 243 244 I-clinical_variable
AST)/alanine 28 40 244 256 I-clinical_variable
aminotransferase 41 57 257 273 I-clinical_variable
( 58 59 274 275 I-clinical_variable
ALT 59 62 275 278 I-clinical_variable
) 62 63 278 279 I-clinical_variable
= 64 65 280 281 O
< 65 66 281 282 O
2.5 67 70 283 286 B-upper_bound
x 71 72 287 288 I-upper_bound
ULN 73 76 289 292 I-upper_bound
; 76 77 292 293 O
AST 78 81 294 297 O
/ 81 82 297 298 O
ALT 82 85 298 301 O
= 86 87 302 303 O
< 87 88 303 304 O
5 89 90 305 306 O
x 91 92 307 308 O
ULN 93 96 309 312 O
if 97 99 313 315 O
liver 100 105 316 321 B-cancer
metastasis 106 116 322 332 I-cancer
is 117 119 333 335 O
present 120 127 336 343 O

Eastern 0 7 344 351 B-clinical_variable
Cooperative 8 19 352 363 I-clinical_variable
Oncology 20 28 364 372 I-clinical_variable
Group 29 34 373 378 I-clinical_variable
( 35 36 379 380 I-clinical_variable
ECOG 36 40 380 384 I-clinical_variable
) 40 41 384 385 I-clinical_variable
performance 42 53 386 397 I-clinical_variable
status 54 60 398 404 I-clinical_variable
= 61 62 405 406 O
< 62 63 406 407 O
2 64 65 408 409 B-upper_bound

Leukocytes 0 10 410 420 B-clinical_variable
> 11 12 421 422 O
= 12 13 422 423 O
3,000 14 19 424 429 B-lower_bound
cells/µL 20 28 430 438 I-lower_bound

Life 0 4 439 443 B-clinical_variable
expectancy 5 15 444 454 I-clinical_variable
of 16 18 455 457 O
greater 19 26 458 465 O
than 27 31 466 470 O
3 32 33 471 472 B-lower_bound
months 34 40 473 479 I-lower_bound
by 41 43 480 482 O
physician 44 53 483 492 O
assessment 54 64 493 503 O

Negative 0 8 504 512 O
serum 9 14 513 518 O
beta 15 19 519 523 O
- 19 20 523 524 O
human 20 25 524 529 O
chorionic 26 35 530 539 O
gonadotropin 36 48 540 552 O
( 49 50 553 554 O
HCG 50 53 554 557 O
) 53 54 557 558 O
test 55 59 559 563 O
( 60 61 564 565 O
female 61 67 565 571 B-gender
patient 68 75 572 579 I-gender
of 76 78 580 582 O
childbearing 79 91 583 595 O
potential 92 101 596 605 O
only 102 106 606 610 O
) 106 107 610 611 O

Patients 0 8 612 620 O
may 9 12 621 624 O
be 13 15 625 627 O
enrolled 16 24 628 636 O
with 25 29 637 641 O
a 30 31 642 643 O
history 32 39 644 651 O
of 40 42 652 654 O
treated 43 50 655 662 O
brain 51 56 663 668 B-cancer
metastases 57 67 669 679 I-cancer
that 68 72 680 684 O
are 73 76 685 688 O
clinically 77 87 689 699 O
stable 88 94 700 706 O
for 95 98 707 710 O
> 99 100 711 712 O
= 100 101 712 713 O
4 102 103 714 715 B-lower_bound
weeks 104 109 716 721 I-lower_bound
prior 110 115 722 727 I-lower_bound
to 116 118 728 730 O
start 119 124 731 736 O
of 125 127 737 739 O
study 128 133 740 745 O
treatment 134 143 746 755 B-treatment

Patients 0 8 756 764 O
may 9 12 765 768 O
not 13 16 769 772 O
be 17 19 773 775 O
receiving 20 29 776 785 O
any 30 33 786 789 O
other 34 39 790 795 O
investigational 40 55 796 811 B-treatment
agents 56 62 812 818 I-treatment
; 62 63 818 819 O
use 64 67 820 823 O
of 68 70 824 826 O
over 71 75 827 831 B-treatment
- 75 76 831 832 I-treatment
the 76 79 832 835 I-treatment
- 79 80 835 836 I-treatment
counter 80 87 836 843 I-treatment
herbal 88 94 844 850 I-treatment
medications 95 106 851 862 I-treatment

Patients 0 8 863 871 O
must 9 13 872 876 O
have 14 18 877 881 O
histologically 19 33 882 896 O
or 34 36 897 899 O
cytologically 37 50 900 913 O
confirmed 51 60 914 923 O
( 61 62 924 925 O
at 62 64 925 927 O
original 65 73 928 936 O
diagnosis 74 83 937 946 O
or 84 86 947 949 O
subsequent 87 97 950 960 O
recurrence 98 108 961 971 O
or 109 111 972 974 O
progression 112 123 975 986 O
) 123 124 986 987 O
solid 125 130 988 993 B-cancer
tumor 131 136 994 999 I-cancer
that 137 141 1000 1004 O
is 142 144 1005 1007 O
metastatic 145 155 1008 1018 O
, 155 156 1018 1019 O
unresectable 157 169 1020 1032 O
, 169 170 1032 1033 O
progressive 171 182 1034 1045 O
, 182 183 1045 1046 O
or 184 186 1047 1049 O
recurrent 187 196 1050 1059 O
, 196 197 1059 1060 O
and 198 201 1061 1064 O
for 202 205 1065 1068 O
which 206 211 1069 1074 O
standard 212 220 1075 1083 O
curative 221 229 1084 1092 O
or 230 232 1093 1095 O
palliative 233 243 1096 1106 O
measures 244 252 1107 1115 O
do 253 255 1116 1118 O
not 256 259 1119 1122 O
exist 260 265 1123 1128 O
or 266 268 1129 1131 O
are 269 272 1132 1135 O
no 273 275 1136 1138 O
longer 276 282 1139 1145 O
effective 283 292 1146 1155 O

Patients 0 8 1156 1164 O
must 9 13 1165 1169 O
not 14 17 1170 1173 O
have 18 22 1174 1178 O
received 23 31 1179 1187 O
prior 32 37 1188 1193 B-treatment
chemotherapy 38 50 1194 1206 I-treatment
or 51 53 1207 1209 O
radiation 54 63 1210 1219 B-treatment
for 64 67 1220 1223 O
< 68 69 1224 1225 O
4 70 71 1226 1227 B-upper_bound
weeks 72 77 1228 1233 I-upper_bound
prior 78 83 1234 1239 I-upper_bound
to 84 86 1240 1242 O
start 87 92 1243 1248 O
of 93 95 1249 1251 O
study 96 101 1252 1257 O
treatment 102 111 1258 1267 B-treatment

Patients 0 8 1268 1276 O
with 9 13 1277 1281 O
a 14 15 1282 1283 O
history 16 23 1284 1291 O
of 24 26 1292 1294 O
noninfectious 27 40 1295 1308 O
pneumonitis 41 52 1309 1320 B-chronic_disease
will 53 57 1321 1325 O
be 58 60 1326 1328 O
excluded 61 69 1329 1337 O
during 70 76 1338 1344 O
the 77 80 1345 1348 O
dose 81 85 1349 1353 O
- 85 86 1353 1354 O
escalation 86 96 1354 1364 O
phase 97 102 1365 1370 O
of 103 105 1371 1373 O
the 106 109 1374 1377 O
trial 110 115 1378 1383 O

Patients 0 8 1384 1392 O
with 9 13 1393 1397 O
uncontrolled 14 26 1398 1410 O
undercurrent 27 39 1411 1423 O
illness 40 47 1424 1431 O
including 48 57 1432 1441 O
, 57 58 1441 1442 O
but 59 62 1443 1446 O
not 63 66 1447 1450 O
limited 67 74 1451 1458 O
to 75 77 1459 1461 O
, 77 78 1461 1462 O
ongoing 79 86 1463 1470 O
or 87 89 1471 1473 O
active 90 96 1474 1480 B-chronic_disease
infection 97 106 1481 1490 I-chronic_disease
, 106 107 1490 1491 O
or 108 110 1492 1494 O
psychiatric 111 122 1495 1506 B-chronic_disease
illness 123 130 1507 1514 I-chronic_disease
/ 130 131 1514 1515 I-chronic_disease
social 131 137 1515 1521 I-chronic_disease
situations 138 148 1522 1532 I-chronic_disease
that 149 153 1533 1537 O
would 154 159 1538 1543 O
limit 160 165 1544 1549 O
compliance 166 176 1550 1560 O
with 177 181 1561 1565 O
study 182 187 1566 1571 O
requirements 188 200 1572 1584 O

Platelets 0 9 1585 1594 B-clinical_variable
> 10 11 1595 1596 O
= 11 12 1596 1597 O
100 13 16 1598 1601 B-lower_bound
, 16 17 1601 1602 I-lower_bound
000 18 21 1603 1606 I-lower_bound
cells/µL 22 30 1607 1615 I-lower_bound

Prothrombin 0 11 1616 1627 B-clinical_variable
time 12 16 1628 1632 I-clinical_variable
( 17 18 1633 1634 I-clinical_variable
PT)/international 18 35 1634 1651 I-clinical_variable
normalized 36 46 1652 1662 I-clinical_variable
ratio 47 52 1663 1668 I-clinical_variable
( 53 54 1669 1670 I-clinical_variable
INR)/ 54 59 1670 1675 I-clinical_variable
activated 60 69 1676 1685 B-clinical_variable
partial 70 77 1686 1693 I-clinical_variable
thromboplastin 78 92 1694 1708 I-clinical_variable
time 93 97 1709 1713 I-clinical_variable
( 98 99 1714 1715 I-clinical_variable
aPTT 99 103 1715 1719 I-clinical_variable
) 103 104 1719 1720 I-clinical_variable
= 105 106 1721 1722 O
< 106 107 1722 1723 O
1.5 108 111 1724 1727 B-upper_bound
x 112 113 1728 1729 I-upper_bound
ULN 114 117 1730 1733 I-upper_bound

Serum 0 5 1734 1739 B-clinical_variable
creatinine 6 16 1740 1750 I-clinical_variable
= 17 18 1751 1752 O
< 18 19 1752 1753 O
1.5 20 23 1754 1757 B-upper_bound
mg 24 26 1758 1760 I-upper_bound
/ 26 27 1760 1761 I-upper_bound
dL 27 29 1761 1763 I-upper_bound
or 30 32 1764 1766 O
a 33 34 1767 1768 O
measured 35 43 1769 1777 O
creatinine 44 54 1778 1788 B-clinical_variable
clearance 55 64 1789 1798 I-clinical_variable
> 65 66 1799 1800 O
= 66 67 1800 1801 O
50 68 70 1802 1804 B-lower_bound
mL 71 73 1805 1807 I-lower_bound
/ 73 74 1807 1808 I-lower_bound
min 74 77 1808 1811 I-lower_bound

Total 0 5 1812 1817 B-clinical_variable
bilirubin 6 15 1818 1827 I-clinical_variable
= 16 17 1828 1829 O
< 17 18 1829 1830 O
1.5 19 22 1831 1834 B-upper_bound
times 23 28 1835 1840 I-upper_bound
the 29 32 1841 1844 I-upper_bound
upper 33 38 1845 1850 I-upper_bound
limit 39 44 1851 1856 I-upper_bound
of 45 47 1857 1859 I-upper_bound
normal 48 54 1860 1866 I-upper_bound
( 55 56 1867 1868 I-upper_bound
ULN 56 59 1868 1871 I-upper_bound
) 59 60 1871 1872 I-upper_bound

Women 0 5 1873 1878 B-gender
of 6 8 1879 1881 O
child 9 14 1882 1887 O
- 14 15 1887 1888 O
bearing 15 22 1888 1895 O
potential 23 32 1896 1905 O
and 33 36 1906 1909 O
men 37 40 1910 1913 O
must 41 45 1914 1918 O
agree 46 51 1919 1924 B-contraception_consent
to 52 54 1925 1927 I-contraception_consent
use 55 58 1928 1931 I-contraception_consent
adequate 59 67 1932 1940 I-contraception_consent
contraception 68 81 1941 1954 I-contraception_consent
( 82 83 1955 1956 O
hormonal 83 91 1956 1964 B-contraception_consent
or 92 94 1965 1967 O
barrier 95 102 1968 1975 B-contraception_consent
method 103 109 1976 1982 I-contraception_consent
of 110 112 1983 1985 I-contraception_consent
birth 113 118 1986 1991 I-contraception_consent
control 119 126 1992 1999 I-contraception_consent
or 127 129 2000 2002 O
abstinence 130 140 2003 2013 B-contraception_consent
) 140 141 2013 2014 O
prior 142 147 2015 2020 O
to 148 150 2021 2023 O
study 151 156 2024 2029 O
entry 157 162 2030 2035 O
and 163 166 2036 2039 O
for 167 170 2040 2043 O
six 171 174 2044 2047 B-upper_bound
months 175 181 2048 2054 I-upper_bound
following 182 191 2055 2064 O
duration 192 200 2065 2073 O
of 201 203 2074 2076 O
study 204 209 2077 2082 O
participation 210 223 2083 2096 O

any 0 3 2097 2100 O
prior 4 9 2101 2106 B-treatment
radiation 10 19 2107 2116 I-treatment
therapy 20 27 2117 2124 I-treatment
must 28 32 2125 2129 O
have 33 37 2130 2134 O
been 38 42 2135 2139 O
administered 43 55 2140 2152 O
> 56 57 2153 2154 O
= 57 58 2154 2155 O
4 59 60 2156 2157 B-lower_bound
weeks 61 66 2158 2163 I-lower_bound
prior 67 72 2164 2169 I-lower_bound
to 73 75 2170 2172 O
start 76 81 2173 2178 O
of 82 84 2179 2181 O
study 85 90 2182 2187 B-treatment
treatment 91 100 2188 2197 I-treatment

the 0 3 2198 2201 O
patient 4 11 2202 2209 O
must 12 16 2210 2214 O
be 17 19 2215 2217 O
recovered 20 29 2218 2227 O
from 30 34 2228 2232 O
the 35 38 2233 2236 O
acute 39 44 2237 2242 O
toxic 45 50 2243 2248 O
effects 51 58 2249 2256 O
of 59 61 2257 2259 O
the 62 65 2260 2263 O
treatment 66 75 2264 2273 B-treatment
prior 76 81 2274 2279 O
to 82 84 2280 2282 O
start 85 90 2283 2288 O
of 91 93 2289 2291 O
study 94 99 2292 2297 B-treatment
treatment 100 109 2298 2307 I-treatment

